Intelligent Asthma Monitoring Devices Market Research 2024: Partnerships Between Pharma and Smart Inhaler Firms to Revolutionize Asthma Management - Global Long-term Forecasts to 2028 and 2033
October 17, 2024 04:01 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Intelligent Asthma Monitoring Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The intelligent asthma monitoring...
Asthma Capitals™ Report Drives Policy Change Agenda
October 08, 2024 08:19 ET
|
Asthma and Allergy Foundation of America
Washington, DC, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America’s (AAFA) 2024 Asthma Capitals™ report highlights the most challenging cities for people with asthma....
Monaghan Medical Wins 2024 AARC Zenith Award
October 03, 2024 04:00 ET
|
Monaghan Medical Corporation
Monaghan Medical Corporation has been honored with the prestigious 2024 Zenith Award from the American Association for Respiratory Care (AARC). This award
Report Names Most Challenging Cities for Living with Asthma in 2024
September 10, 2024 07:00 ET
|
Asthma and Allergy Foundation of America
Washington, DC, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Today, the Asthma and Allergy Foundation of America (AAFA) released its 2024 Asthma Capitals™ report highlighting the most challenging cities for...
Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress
September 09, 2024 08:00 ET
|
Upstream Bio, Inc.
Upstream gives oral presentation of clinical data for verekitug in patients with severe asthma at European Respiratory Society congress
Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadership in Respiratory Diseases
August 26, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
20 abstracts, including 4 oral presentations, offer new treatment insights for chronic obstructive pulmonary disease (COPD), asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) Data from...
Warning: September Asthma Spike Ahead
August 22, 2024 07:00 ET
|
Asthma and Allergy Foundation of America
Washington, DC, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) today warned about a combination of factors coming together to make September the worst month of...
Acute Respiratory Distress Syndrome Analysis Report 2024: A $2.36 Billion Market by 2032 from $1.23 Billion in 2023
July 18, 2024 06:27 ET
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Report by Type, End User, Regions and Company Analysis 2024-2032" report has been added to ...
Bronchiectasis Opportunity Assessment and 10 Year Forecast 2023-2033
June 06, 2024 09:09 ET
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Bronchiectasis: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering. This report covers the 8 Major...
Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
May 22, 2024 11:15 ET
|
Upstream Bio, Inc.
Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024